期刊论文详细信息
The Journal of Headache and Pain
Release of PACAP-38 in episodic cluster headache patients – an exploratory study
Short Report
Lars Edvinsson1  Eszter Tóth2  Nikoletta Szabó2  Zsigmond Tamás Kincses2  Tamás Körtési2  János Tajti2  Délia Szok2  Árpád Párdutz2  Bernadett Tuka3  László Vécsei3  Teréz Bagoly4  Zsuzsanna Helyes5 
[1] Department of Clinical Sciences, Division of Experimental Vascular Research, Lund University, Sölvegatan 17, BMC A13, 22184, Lund, Sweden;Department of Neurology, Faculty of Medicine, University of Szeged, Semmelweis u. 6, H-6725, Szeged, Hungary;Department of Neurology, Faculty of Medicine, University of Szeged, Semmelweis u. 6, H-6725, Szeged, Hungary;MTA-SZTE Neuroscience Research Group, Semmelweis u. 6, H-6725, Szeged, Hungary;Department of Pharmacology and Pharmacotherapy, Faculty of Medicine, University of Pécs, Szigeti u. 12, H-7624, Pécs, Hungary;Department of Pharmacology and Pharmacotherapy, Faculty of Medicine, University of Pécs, Szigeti u. 12, H-7624, Pécs, Hungary;János Szentágothai Research Center, University of Pécs, Ifjúság útja 20, H-7624, Pécs, Hungary;MTA-PTE NAP B Pain Research Group, University of Pécs, Szigeti u. 12, H-7624, Pécs, Hungary;
关键词: Episodic cluster headache;    Plasma PACAP-38-LI;    Inter-bout period;    Ictal phase;   
DOI  :  10.1186/s10194-016-0660-7
 received in 2016-05-22, accepted in 2016-07-22,  发布年份 2016
来源: Springer
PDF
【 摘 要 】

BackgroundActivation of the trigeminal-autonomic reflex, involving the trigeminal ganglion, the superior salivatory nucleus and the sphenopalatine ganglion (SPG) is crucial in the pathophysiology of cluster headache (CH). Since pituitary adenylate cyclase-activating polypeptide-38 (PACAP-38) is present both in the SPG and the trigeminal ganglion (TG) and its role in migraine has been described, our aim was to determine the plasma PACAP-38 levels in different phases of episodic CH (ECH).Peripheral cubital fossa blood samples were taken during the ictal and inter-bout periods of male ECH patients and from age-matched healthy controls (n = 9). Plasma PACAP-38-like immunoreactivity (LI) was measured with specific and sensitive radioimmunoassay.FindingsSignificantly lower plasma PACAP-38-LI was detected in the inter-bout period of ECH patients than in healthy controls. However, PACAP-38 was significantly elevated in the plasma during CH attacks as compared to the inter-bout phase in the same subjects (n = 5).ConclusionsThis exploratory study suggests that PACAP-38 may be released during the attacks of ECH. Further patients and long-term follow-up are necessary to reveal its function.

【 授权许可】

CC BY   
© The Author(s). 2016

【 预 览 】
附件列表
Files Size Format View
RO202310133142333ZK.pdf 537KB PDF download
【 参考文献 】
  • [1]
  • [2]
  • [3]
  • [4]
  • [5]
  • [6]
  • [7]
  • [8]
  • [9]
  • [10]
  • [11]
  • [12]
  • [13]
  • [14]
  • [15]
  • [16]
  • [17]
  • [18]
  • [19]
  • [20]
  • [21]
  • [22]
  • [23]
  • [24]
  • [25]
  • [26]
  • [27]
  • [28]
  • [29]
  • [30]
  • [31]
  • [32]
  • [33]
  • [34]
  • [35]
  • [36]
  文献评价指标  
  下载次数:2次 浏览次数:1次